These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10912117)

  • 1. [Primary coronary heart disease prevention in general practice. How does one recognize and define a risk patient?].
    Schwandt P
    MMW Fortschr Med; 1999 Oct; 141(43):26-8. PubMed ID: 10912117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factor grading for prevention of coronary artery disease].
    Erbel R; Siffert W; Möhlenkamp S; Schmermund A
    Dtsch Med Wochenschr; 2003 Feb; 128(7):330-6. PubMed ID: 12584660
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing family history of heart disease in primary care consultations: a qualitative study.
    Hall R; Saukko PM; Evans PH; Qureshi N; Humphries SE
    Fam Pract; 2007 Oct; 24(5):435-42. PubMed ID: 17728290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of peripheral vascular disease on long-term survival after coronary artery bypass graft surgery.
    Chu D; Bakaeen FG; Wang XL; Dao TK; LeMaire SA; Coselli JS; Huh J
    Ann Thorac Surg; 2008 Oct; 86(4):1175-80. PubMed ID: 18805156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hyperlipidaemia.
    Stocks N; Allan J; Mansfield PR
    Aust Fam Physician; 2005 Jun; 34(6):447-53. PubMed ID: 15931403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol reduction in patients with lower limb atherosclerotic disease.
    Bismuth J; Kofoed SC; Sillesen HH
    Dan Med Bull; 2002 Feb; 49(1):61-4. PubMed ID: 11894724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary prevention of coronary heart disease with aspirin].
    Kübler W
    Z Kardiol; 2004; 93 Suppl 2():II33-6. PubMed ID: 15021994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
    Chin BS; Futaba K; Jethwa A; Lip GY
    Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
    EUROASPIRE II Study Group
    Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary heart disease: account of a preventive clinic in general practice.
    Wrench JG; Irvine R
    J R Coll Gen Pract; 1984 Sep; 34(266):477-81. PubMed ID: 6471036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The general practitioner's role in the prevention of coronary heart disease.
    Fowler G
    Practitioner; 1986 Oct; 230(1420):859-62, 864. PubMed ID: 3658893
    [No Abstract]   [Full Text] [Related]  

  • 16. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the management of hyperlipidaemia in general practice. Towards the primary prevention of coronary heart disease. Royal College of General Practitioners.
    Occas Pap R Coll Gen Pract; 1992 Mar; (55):1-15. PubMed ID: 1296829
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking status, sports participation and mortality from coronary heart disease.
    Noda H; Iso H; Toyoshima H; Date C; Yamamoto A; Kikuchi S; Koizumi A; Kondo T; Watanabe Y; Wada Y; Inaba Y; Tamakoshi A;
    Heart; 2008 Apr; 94(4):471-5. PubMed ID: 17916664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of risk factors in patients with coronary heart disease after in-patient rehabilitation].
    Küpper-Nybelen J; Rothenbacher D; Hahmann H; Wüsten B; Brenner H
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1525-30. PubMed ID: 12854061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.